# Stellus Capital Investment Corp: Form 10-Q for the period ended Sep 30, 2021

- Company: [Stellus Capital Investment Corp](/companies/scm.md) (CIK 1551901)
- Form: 10-Q
- Filed: 2021-10-28
- Accepted by EDGAR: Oct 28, 2021, 16:17 ET
- Period: 2021-09-30
- Accession: 0001104659-21-131054
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1551901/000110465921131054/tm2126317d1_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551901/000110465921131054/

## Management's discussion and analysis

As filed, 64,640 characters.

### Forward-Looking Statements

Some of the statements in this quarterly report on Form 10-Q constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained in this quarterly report on Form 10-Q involve risks and uncertainties, related to the current COVID-19 pandemic and otherwise, including statements as to:

- our future operating results;
- our business prospects and the prospects of our portfolio companies;
- the effect of investments that we expect to make;
- our contractual arrangements and relationships with third parties;
- actual and potential conflicts of interest with Stellus Capital Management, LLC (“Stellus Capital” or the “Advisor);
- the dependence of our future success on the general economy and its effect on the industries in which we invest;
- the ability of our portfolio companies to achieve their objectives;
- the use of borrowed money to finance a portion of our investments;
- the adequacy of our financing sources and working capital;
- the timing of cash flows, if any, from the operations of our portfolio companies;
- the ability of Stellus Capital to locate suitable investments for us and to monitor and administer our investments;
- the ability of Stellus Capital to attract and retain highly talented professionals;
- our ability to maintain our qualification as a RIC and as a BDC; and
- the effect of future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities) and conditions in our operating areas, particularly with respect to business development companies or RICs.

Such forward-looking statements may include statements preceded by, followed by or that otherwise include the words “may,” “might,” “will,” “intend,” “should,” “could,” “can,” “would,” “expect,” “believe,” “estimate,” “anticipate,” “predict,” “potential,” “plan” or similar words.

We have based the forward-looking statements included in this quarterly report on Form 10-Q on information available to us on the date of this quarterly report on Form 10-Q. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or Securities and Exchange Commission (“SEC”) rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

### Overview

We were organized as a Maryland corporation on May 18, 2012, and formally commenced operations on November 7, 2012. Our investment objective is to maximize the total return to our stockholders in the form of current income and capital appreciation through debt and related equity investments in middle-market companies.

We are an externally managed, non-diversified, closed-end investment company that has elected to be regulated as a BDC under the 1940 Act. Our investment activities are managed by our investment adviser, Stellus Capital.

As a BDC, we are required to comply with certain regulatory requirements. For instance, as a BDC, we may not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets. Qualifying assets include investments in “eligible portfolio companies.” Under the relevant SEC rules, the term “eligible portfolio company” includes all private operating companies, operating companies whose securities are not listed on a national securities exchange, and certain public operating companies that have listed their securities on a national securities exchange and have a market capitalization of less than $250 million, in each case organized and with their principal of business in the United States.

We have elected to be treated for U.S. federal tax purposes as a RIC under Subchapter M of the Code and intend to operate in a manner to qualify annually for a tax treatment applicable to RICs. To maintain our qualification as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements. As of September 30, 2021, we were in compliance with the RIC requirements. As a RIC, we generally will not have to pay corporate-level U.S. federal income taxes on any income we distribute to our stockholders.

On March 23, 2018, the Small Business Credit Availability Act (the “SBCAA”) was signed into law, which included various changes to regulations under the federal securities laws that impact BDCs. The SBCAA included changes to the 1940 Act to allow BDCs to decrease their asset coverage requirement to 150% from 200% under certain circumstances

On April 4, 2018, the Board, including a required majority (as such term is defined in Section 57(o) of the 1940 Act) of the Board, approved the application of the modified asset coverage requirements set forth in Section 61(a)(2) of the 1940 Act. At our 2018 annual meeting of stockholders our stockholders also approved the application of the modified asset coverage requirements set forth in Section 61(a)(2) of the 1940 Act. As a result, the asset coverage ratio applicable to us was decreased from 200% to 150%, effective June 29, 2018. As of September 30, 2021, our asset coverage ratio was 195%. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

### COVID-19 Developments

On March 11, 2020, the World Health Organization declared COVID-19 a pandemic and recommended containment and mitigation measures worldwide. The COVID-19 pandemic has had a significant impact on the U.S. and global economy. Each portfolio company has been assessed on an individual basis to identify the impact of the COVID-19 pandemic on the valuation of our investments in such company. We believe that any such COVID-19 pandemic impacts have been reflected in the valuation of our investments.

The global impact of the outbreak continues to evolve, and many countries have reacted by instituting quarantines, prohibitions on travel and the closure of offices, businesses, schools, retail stores and other public venues. Businesses are also implementing similar precautionary measures. Such measures, as well as the general uncertainty surrounding the dangers and impact of the COVID-19 pandemic, have created significant disruption in supply chains and economic activity. While several countries, as well as certain states in the United States, have begun to lift public health restrictions with the view to reopening their economies, recurring COVID-19 outbreaks have led to the re-introduction of such restrictions in certain states in the United States and globally and could continue to lead to the re-introduction of such restrictions elsewhere. The Federal Food and Drug Administration authorized vaccines produced for emergency use starting in December 2020, and such vaccines have been distributed nationally; however, it remains unclear how quickly the vaccines will continue to be be distributed nationwide and globally or when “herd immunity” will be achieved and the restrictions that were imposed to slow the spread of the virus will be lifted entirely. The delay in distributing the vaccines could lead people to continue to self-isolate and not participate in the economy at pre-pandemic levels for a prolonged period of time. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and we anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States and other major markets.

As COVID-19 continues to spread, the potential impacts, including a global, regional, or other economic recession, remain uncertain and difficult to assess. The extent of the impact of the COVID-19 pandemic on the financial performance of our current and future investments will depend on future developments, including the duration and spread of the virus, related advisories and restrictions, and the health of the financial markets and economy, all of which are highly uncertain and cannot be predicted. To the extent our portfolio companies are adversely impacted by the effects of the COVID-19 pandemic, it may have a material adverse impact on our future net investment income, the fair value of our portfolio investments and our financial condition.

### Economic outlook

The Federal Food and Drug Administration authorized vaccines produced for emergency use starting in December 2020, it remains unclear how quickly the vaccines will be distributed nationwide and globally or when “herd immunity” will be achieved and the restrictions that were imposed to slow the spread of the virus will be lifted entirely. The delay in distributing the vaccines could lead people to continue to self- isolate and not participate in the economy at pre-pandemic levels for a prolonged period. The COVID-19 pandemic could have a continued adverse impact on economic and market conditions and trigger a period of global economic slowdown. The COVID-19 pandemic presents material uncertainty and risks with respect to the underlying value of our portfolio companies and with respect to our business, financial condition, results of operations, and cash flows, such as the potential negative impact to financing arrangements, increased costs of operations, changes in law and/or regulation, and uncertainty regarding government and regulatory policy.

### Our COVID-19 response

Since the onset of the COVID-19 pandemic, we have been in regular contact with all of our portfolio companies and/or their sponsors to assess among other things their ability to function in the new environment. Discussions have addressed the portfolio companies’ liquidity position, expected covenant compliance, and the health of their workforce and customers.

### Financial impact

We will continue to closely monitor the financial condition of our portfolio companies as part of our efforts to mitigate the impact of the COVID-19 pandemic. Historical information may be relatively less significant.

### Portfolio Composition and Investment Activity

### Portfolio Composition

We originate and invest primarily in privately-held middle-market companies (typically those with $5.0 million to $50.0 million of EBITDA) through first lien (including unitranche), second lien, and unsecured debt financing, often times with a corresponding equity investment.

As of September 30, 2021, we had $785.7 million (at fair value) invested in 74 portfolio companies. As of September 30, 2021, our portfolio included approximately 81% of first lien debt, 7% of second lien debt, 3% of unsecured debt and 9% of equity investments at fair value. The composition of our investments at cost and fair value as of September 30, 2021 was as follows:

|  | Cost | Fair Value |
| --- | ---: | ---: |
| Senior Secured – First Lien(1) | $640,788,167 | $638,474,668 |
| Senior Secured – Second Lien | 79,793,715 | 58,044,145 |
| Unsecured Debt | 18,768,588 | 18,889,424 |
| Equity | 47,684,288 | 70,290,513 |
| Total Investments | $787,034,758 | $785,698,750 |

(1) Includes unitranche investments, which account for 10.8% of our portfolio at fair value. Unitranche structures may combine characteristics of first lien senior secured as well as second lien and/or subordinated loans and our unitranche loans will expose us to the risks associated with second lien and subordinated loans to the extent we invest in the “last-out” tranche.

As of December 31, 2020, we had $653.4 million (at fair value) invested in 66 portfolio companies. As of December 31, 2020, our portfolio included approximately 78% of first lien debt, 11% of second lien debt, 3% of unsecured debt and 8% of equity investments at fair value. The composition of our investments at cost and fair value as of December 31, 2020 was as follows:

|  | Cost | Fair Value |
| --- | ---: | ---: |
| Senior Secured – First Lien(1) | $508,060,059 | $508,673,064 |
| Senior Secured – Second Lien | 93,636,285 | 70,720,186 |
| Unsecured Debt | 22,212,888 | 21,191,245 |
| Equity | 34,719,734 | 52,840,000 |
| Total Investments | $658,628,966 | $653,424,495 |

(1) Includes unitranche investments, which account for 13.0% of our portfolio at December 31, 2020 at fair value. Unitranche structures may combine characteristics of first lien senior secured as well as second lien and/or subordinated loans and our unitranche loans will expose us to the risks associated with second lien and subordinated loans to the extent we invest in the “last-out” tranche.

Our investment portfolio may contain loans that are in the form of lines of credit or revolving credit facilities, which require us to provide funding when requested by portfolio companies in accordance with the terms and conditions of the underlying loan agreements. As of September 30, 2021 and December 31, 2020, we had unfunded commitments of $27.3 million and $28.9 million, respectively, to provide debt financing for 25 and 19 portfolio companies, respectively. As of September 30, 2021, we had sufficient liquidity (through cash on hand and available borrowings under the Credit Facility) to fund such unfunded commitments should the need arise.

The following is a summary of geographical concentration of our investment portfolio as of September 30, 2021:

|  | Cost | Fair Value | % of Total Investments at Fair Value |
| --- | ---: | ---: | ---: |
| California | $134,934,002 | $140,149,278 | 17.84% |
| Texas | 153,685,119 | 137,561,456 | 17.51% |
| Illinois | 70,410,297 | 71,619,407 | 9.12% |
| Arizona | 50,756,093 | 54,977,354 | 7.00% |
| Pennsylvania | 37,478,573 | 37,440,711 | 4.77% |
| New Jersey | 38,098,810 | 35,942,765 | 4.57% |
| Canada | 34,853,727 | 34,994,775 | 4.45% |
| Ohio | 31,969,747 | 33,689,339 | 4.29% |
| Wisconsin | 25,928,215 | 26,285,445 | 3.35% |
| Washington | 22,751,096 | 22,809,080 | 2.90% |
| New York | 18,887,234 | 20,849,341 | 2.65% |
| United Kingdom | 21,307,905 | 19,818,875 | 2.53% |
| Georgia | 11,189,933 | 18,646,664 | 2.37% |
| Indiana | 17,684,153 | 17,811,311 | 2.27% |
| Maryland | 16,871,320 | 17,018,750 | 2.17% |
| Minnesota | 15,868,408 | 15,807,229 | 2.01% |
| Colorado | 15,172,493 | 15,195,900 | 1.93% |
| Florida | 13,126,961 | 13,449,457 | 1.71% |
| District of Columnbia | 11,929,982 | 12,762,500 | 1.62% |
| Missouri | 9,893,021 | 10,565,000 | 1.34% |
| North Carolina | 10,520,082 | 10,481,000 | 1.33% |
| Massachusetts | 10,297,773 | 10,297,773 | 1.31% |
| Tennessee | 4,306,570 | 4,323,554 | 0.55% |
| Puerto Rico | 8,613,244 | 2,161,786 | 0.28% |
| Virginia | 500,000 | 630,000 | 0.08% |
| Utah | - | 410,000 | 0.05% |
|  | $787,034,758 | $785,698,750 | 100.00% |

60

The following is a summary of geographical concentration of our investment portfolio as of December 31, 2020:

|  | Cost | Fair Value | % of Total Investments at fair value |
| --- | ---: | ---: | ---: |
| Texas | $151,640,862 | $135,146,776 | 20.68% |
| California | 86,050,467 | 92,069,851 | 14.09% |
| Illinois | 57,330,756 | 57,535,404 | 8.81% |
| Arizona | 50,822,139 | 52,015,600 | 7.96% |
| New Jersey | 38,228,359 | 37,765,139 | 5.78% |
| Ohio | 34,109,657 | 35,827,682 | 5.48% |
| Wisconsin | 22,721,856 | 22,827,500 | 3.49% |
| Canada | 21,318,659 | 21,540,925 | 3.30% |
| New York | 19,527,594 | 20,547,579 | 3.14% |
| Tennessee | 19,832,576 | 19,959,613 | 3.05% |
| United Kingdom | 20,159,650 | 18,727,500 | 2.87% |
| South Carolina | 15,834,471 | 18,132,490 | 2.77% |
| Indiana | 17,741,889 | 18,026,339 | 2.76% |
| Maryland | 16,970,057 | 17,064,250 | 2.61% |
| Florida | 12,404,739 | 12,299,545 | 1.88% |
| Alabama | 12,252,768 | 12,252,768 | 1.88% |
| Washington | 11,803,768 | 11,801,363 | 1.81% |
| Missouri | 9,956,554 | 10,720,000 | 1.64% |
| Pennsylvania | 9,884,148 | 9,900,000 | 1.52% |
| Virginia | 7,505,287 | 7,759,020 | 1.19% |
| Washington, D.C. | 6,937,907 | 7,030,512 | 1.08% |
| Georgia | 685,000 | 6,420,000 | 0.98% |
| North Carolina | 4,979,153 | 2,925,000 | 0.45% |
| Puerto Rico | 8,613,244 | 2,589,639 | 0.40% |
| Massachusetts | 1,317,406 | 1,780,000 | 0.27% |
| Utah | - | 760,000 | 0.11% |
|  | $658,628,966 | $653,424,495 | 100.00% |

61

The following is a summary of industry concentration of our investment portfolio as of September 30, 2021:

|  | Cost | Fair Value | % of Total Investments at Fair Value |
| --- | ---: | ---: | ---: |
| Services: Business | $159,012,118 | $168,449,139 | 21.44% |
| Healthcare & Pharmaceuticals | 99,744,266 | 99,533,534 | 12.67% |
| Aerospace & Defense | 81,055,347 | 79,828,943 | 10.16% |
| Media: Advertising, Printing & Publishing | 45,606,217 | 43,306,492 | 5.51% |
| Capital Equipment | 37,102,848 | 38,713,465 | 4.93% |
| Media: Broadcasting & Subscription | 31,303,573 | 35,080,631 | 4.46% |
| Beverage, Food, & Tobacco | 33,878,852 | 34,401,058 | 4.38% |
| Consumer Goods: Non-durable | 29,645,617 | 29,124,666 | 3.71% |
| Consumer Goods: Durable | 28,461,095 | 28,855,225 | 3.67% |
| Software | 21,531,074 | 23,866,607 | 3.04% |
| Services: Consumer | 38,047,798 | 21,893,601 | 2.79% |
| Education | 21,395,007 | 21,555,671 | 2.74% |
| High Tech Industries | 21,414,367 | 21,540,925 | 2.74% |
| Transportation & Logistics | 18,172,123 | 18,278,855 | 2.33% |
| Containers, Packaging, & Glass | 17,587,981 | 17,828,219 | 2.27% |
| Metals & Mining | 16,871,320 | 17,018,750 | 2.17% |
| FIRE: Real Estate | 15,708,184 | 15,708,184 | 2.00% |
| Chemicals, Plastics, & Rubber | 14,688,506 | 14,681,563 | 1.87% |
| Automotive | 11,055,168 | 11,025,000 | 1.40% |
| Construction & Building | 10,504,933 | 10,516,664 | 1.34% |
| Environmental Industries | 10,766,852 | 10,270,000 | 1.31% |
| Utilities: Oil & Gas | 9,897,299 | 9,850,000 | 1.25% |
| Energy: Oil & Gas | 11,077,017 | 9,531,558 | 1.21% |
| Finance | 2,507,196 | 4,590,000 | 0.58% |
| Hotel, Gaming, & Leisure | - | 250,000 | 0.03% |
|  | $787,034,758 | $785,698,750 | 100.00% |

62

*The following is a summary of industry concentration of our investment portfolio as of December 31, 2020:*

|  | Cost | Fair Value | % of Total Investments at fair value |
| --- | ---: | ---: | ---: |
| Services: Business | $102,005,864 | $109,873,364 | 16.82% |
| Healthcare & Pharmaceuticals | 87,198,279 | 82,945,887 | 12.69% |
| Aerospace & Defense | 53,615,886 | 52,184,338 | 7.99% |
| Beverage, Food, & Tobacco | 39,339,090 | 41,012,620 | 6.28% |
| Media: Broadcasting & Subscription | 31,889,423 | 34,418,869 | 5.27% |
| High Tech Industries | 33,571,427 | 33,793,693 | 5.17% |
| Consumer Goods: Durable | 27,802,124 | 27,780,032 | 4.25% |
| Environmental Industries | 25,454,549 | 24,977,427 | 3.82% |
| Education | 26,428,607 | 24,494,108 | 3.75% |
| Services: Consumer | 38,026,487 | 22,600,924 | 3.46% |
| Media: Advertising, Printing & Publishing | 21,903,057 | 21,348,217 | 3.27% |
| Capital Equipment | 20,005,255 | 20,680,904 | 3.17% |
| Finance | 18,016,762 | 19,435,000 | 2.97% |
| Transportation & Logistics | 18,690,276 | 18,944,945 | 2.90% |
| Retail | 15,834,471 | 18,132,490 | 2.77% |
| Containers, Packaging, & Glass | 17,853,813 | 17,890,000 | 2.74% |
| Metals & Mining | 16,970,057 | 17,064,250 | 2.61% |
| Consumer goods: non-durable | 13,272,383 | 12,930,000 | 1.98% |
| Automotive | 11,028,125 | 11,028,125 | 1.69% |
| Construction & Building | 10,446,055 | 10,750,000 | 1.65% |
| Energy: Oil & Gas | 11,015,013 | 9,991,177 | 1.53% |
| Utilities: Oil & Gas | 9,884,148 | 9,900,000 | 1.52% |
| Chemicals, Plastics, & Rubber | 6,605,024 | 6,808,125 | 1.04% |
| Software | 1,772,791 | 4,430,000 | 0.66% |
| Hotel, Gaming, & Leisure | - | 10,000 | —% |
|  | $658,628,966 | $653,424,495 | 100.00% |

At September 30, 2021, our average portfolio company investment at both amortized cost and fair value was approximately $10.6 million, and our largest portfolio company investment at amortized cost and fair value was $21.4 million and $23.0 million, respectively. At December 31, 2020, our average portfolio company investment at amortized cost and fair value was approximately $10.0 million and $9.9 million, respectively, and our largest portfolio company investment at amortized cost and fair value was approximately $21.4 million and $21.6 million, respectively.

At September 30, 2021, 95% of our debt investments bore interest based on floating rates (subject to interest rate floors), such as LIBOR, and 5% bore interest at fixed rates. At December 31, 2020, 93% of our debt investments bore interest based on floating rates (subject to interest rate floors), such as LIBOR, and 7% bore interest at fixed rates.

The weighted average yield on all of our debt investments as of September 30, 2021 and December 31, 2020 was 8.3% and 8.3%, respectively. The weighted average yield on all of our investments, including non-income producing equity positions, investments as of September 30, 2021 and December 31, 2020 was approximately 7.8% and 7.9%, respectively. The weighted average yield was computed using the effective interest rates for all of our debt investments, including accretion of original issue discount. The weighted average yield of our debt investments is not the same as a return on investment for our stockholder, but, rather relates to a portion of our investment portfolio and is calculated before the payment of all of our and our subsidiaries’ fees and expenses.

As of September 30, 2021 and December 31, 2020, we had cash and cash equivalents of $37.8 million and $18.5 million, respectively.

### Investment Activity

During the nine months ended September 30, 2021, we made an aggregate of $243.3 million (net of fees) of investments in 18 new portfolio companies and 24 existing portfolio companies. During the nine months ended September 30, 2021, we received an aggregate of $123.6 million in proceeds from repayments of our investments.

Our level of investment activity can vary substantially from period to period depending on many factors, including the amount of debt and equity capital required by middle-market companies, the level of merger and acquisition activity, the general economic environment and the competitive environment for the types of investments we make.

### Asset Quality

In addition to various risk management and monitoring tools, Stellus Capital uses an investment rating system to characterize and monitor the credit profile and expected level of returns on each investment in our investment portfolio. This investment rating system uses a five-level numeric scale. The following is a description of the conditions associated with each investment category:

- Investment Category 1 is used for investments that are performing above expectations, and whose risks remain favorable compared to the expected risk at the time of the original investment.
- Investment Category 2 is used for investments that are performing within expectations and whose risks remain neutral compared to the expected risk at the time of the original investment. All new loans are initially rated 2.
- Investment Category 3 is used for investments that are performing below expectations and that require closer monitoring, but where no loss of return or principal is expected. Portfolio companies with a rating of 3 may be out of compliance with financial covenants.
- Investment Category 4 is used for investments that are performing substantially below expectations and whose risks have increased substantially since the original investment. These investments are often in work out. Investments with a rating of 4 are those for which some loss of return but no loss of principal is expected.
- Investment Category 5 is used for investments that are performing substantially below expectations and whose risks have increased substantially since the original investment. These investments are almost always in work out. Investments with a rating of 5 are those for which some loss of return and principal is expected.

*(dollars in millions)*

*(dollars in millions)*

| Investment Category | As of September 30, 2021 Fair Value | % of Total Portfolio | Number of Portfolio Companies | As of December 31, 2020 Fair Value | % of Total Portfolio | Number of Portfolio Companies |
| ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| 1 | $181.4 | 23% | 19 | $87.3 | 14% | 12 |
| 2 | 501.3 | 64% | 45 | 496.5 | 76% | 45 |
| 3 | 95.1 | 12% | 7 | 61.3 | 9% | 6 |
| 4 | 3.7 | 0% | 1 | — | —% | — |
| 5 | 4.3 | 1% | 2 | 8.3 | 1% | 3 |
| Total | $785.7 | 100% | 74 | $653.4 | 100% | 66 |

### Loans and Debt Securities on Non-Accrual Status

We will not accrue interest on loans and debt securities if we have reason to doubt our ability to collect such interest. As of September 30, 2021, we had four loans on non-accrual status, which represented approximately 4.2% of our loan portfolio at cost and 1.1% at fair value. As of December 31, 2020, we had three loans on non-accrual status that represented approximately 4.3% of our loan portfolio at cost and 1.0% at fair value. As of September 30, 2021 and December 31, 2020, $8.4 million and $7.1 million of income from investments on non-accrual has not been accrued, respectively.

### Results of Operations

An important measure of our financial performance is net increase (decrease) in net assets resulting from operations, which includes net investment income (loss), net realized gain (loss) and net unrealized appreciation (depreciation). Net investment income (loss) is the difference between our income from interest, dividends, fees and other investment income and our operating expenses including interest on borrowed funds. Net realized gain (loss) on investments is the difference between the proceeds received from dispositions of portfolio investments and their amortized cost. Net unrealized appreciation (depreciation) on investments is the net change in the fair value of our investment portfolio.

### Comparison of the Three Months and Nine Months Ended September 30, 2021 and 2020

#### Revenues

We generate revenue in the form of interest income on debt investments and capital gains and distributions, if any, on investment securities that we may acquire in portfolio companies. Our debt investments typically have a term of five to seven years and bear interest at primarily floating rates. Interest on our debt securities is generally payable quarterly. Payments of principal on our debt investments may be amortized over the stated term of the investment, deferred for several years or due entirely at maturity. In some cases, our debt investments may pay interest in-kind, or PIK interest. Any outstanding principal amount of our debt securities and any accrued but unpaid interest will generally become due at the maturity date. The level of interest income we receive is directly related to the balance of interest-bearing investments multiplied by the weighted average yield of our investments. We expect that the total dollar amount of interest and any dividend income that we earn will increase as the size of our investment portfolio increases. In addition, we may generate revenue in the form of prepayment fees, commitment, loan origination, structuring or due diligence fees, fees for providing significant managerial assistance and consulting fees.

The following shows the breakdown of investment income for the three and nine months ended September 30, 2021 and 2020.

*(dollars in millions)*

*(dollars in millions)*

|  | Three months ended September 30, 2021 | 2020 | Nine months ended September 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Interest income(1) | $16.2 | $13.7 | $44.2 | $41.6 |
| PIK interest | 0.2 | - | 0.6 | 0.6 |
| Miscellaneous fees(1) | 0.6 | 0.3 | 1.3 | 0.9 |
| Total | $17.0 | $14.0 | $46.1 | $43.1 |

(1) For the three and nine months ended September 30, 2021, we recognized $0.8 million and $1.3 million, respectively, of non-recurring income related to early repayments, and amendments to specific loan positions. For the three and nine months ended September 30, 2020, we recognized $0.5 million and $1.5 million, respectively, of non-recurring income related to early repayments, amendments to specific loan positions, and the recognition of previously reserved income from a prior period.

The increase in total income for the three and nine months ended September 30, 2021 is due to the growth in the overall investment portfolio.

#### Expenses

Our primary operating expenses include the payment of fees to Stellus Capital under the investment advisory agreement, our allocable portion of overhead expenses under the administration agreement and other operating costs described below. We bear all other out-of-pocket costs and expenses of our operations and transactions, which may include:

- organization and offering;
- calculating our net asset value (including the cost and expenses of any independent valuation firm);
- fees and expenses payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs for us and in monitoring our investments and performing due diligence on our prospective portfolio companies or otherwise relating to, or associated with, evaluating and making investments;
- interest payable on debt, if any, incurred to finance our investments and expenses related to unsuccessful portfolio acquisition efforts;
- base management and incentive fees;
- administration fees and expenses, if any, payable under the administration agreement (including our allocable portion of Stellus Capital’s overhead in performing its obligations under the administration agreement, including rent and the allocable portion of the cost of our Chief Compliance Officer and Chief Financial Officer and their respective staff);
- transfer agent, dividend paying agent and custodial fees and expenses;
- U.S. federal and state registration fees;
- all costs of registration and listing our securities on any securities exchange;
- U.S. federal, state and local taxes;
- independent directors’ fees and expenses;
- costs of preparing and filing reports or other documents required by the SEC or other regulators;
- costs of distributing any reports, proxy statements or other notices to stockholders, including printing costs;
- costs and fees associated with any fidelity bond, directors and officers/errors and omissions liability insurance, and any other insurance premiums;
- direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs;
- proxy voting expenses; and
- all other expenses incurred by us or Stellus Capital in connection with administering our business.

The following shows the breakdown of operating expenses for the three and nine months ended September 30, 2021 and 2020.

*(dollars in millions)*

*(dollars in millions)*

| Operating Expenses | Three months ended September 30, 2021 | 2020 | Nine months ended September 30, 2021 | 2020 |
| --- | ---: | ---: | ---: | ---: |
| Management fees | $3.5 | $2.8 | $9.7 | $8.3 |
| Valuation Fees | 0.1 | 0.1 | 0.3 | 0.2 |
| Administrative services expenses | 0.4 | 0.4 | 1.4 | 1.3 |
| Income incentive fees | 1.5 | 0.5 | 1.5 | 2.0 |
| Capital gain incentive fees | 1.7 | - | 1.8 | (0.9) |
| Professional fees | 0.3 | 0.2 | 0.8 | 0.8 |
| Directors’ fees | 0.1 | 0.1 | 0.2 | 0.3 |
| Insurance expense | 0.1 | 0.1 | 0.4 | 0.3 |
| Interest expense and other fees | 4.9 | 3.9 | 13.9 | 12.2 |
| Income tax expense | 0.2 | 0.4 | 0.7 | 0.9 |
| Other general and administrative | 0.2 | 0.2 | 0.8 | 0.7 |
| Total Operating Expenses | $13.0 | $8.7 | $31.5 | $26.1 |

The increase in operating expenses for the three months ended September 30, 2021 and nine months ended September 30, 2021, was due to (1) higher interest expense as a result of higher outstanding balances on our SBA-guaranteed debentures and Notes, (2) higher management fees due to a larger investment portfolio, and (3) higher incentive fees due to portfolio performance.

#### Net Investment Income

For the three months ended September 30, 2021, net investment income was $4.1 million, or $0.21 per common share (based on 19,486,003 weighted-average common shares outstanding at September 30, 2021).

For the three months ended September 30, 2020, net investment income was $5.3 million, or $0.27 per common share (based on 19,486,003 weighted-average common shares outstanding at September 30, 2020).

For the nine months ended September 30, 2021, net investment income was $14.7 million, or $0.75 per common share (based on 19,486,003 weighted-average common shares outstanding at September 30, 2021).

For the nine months ended September 30, 2020, net investment income was $17.0 million, or $0.87 per common share (based on 19,466,647 weighted-average common shares outstanding at September 30, 2020).

Net investment income for the three months ended September 30, 2021 decreased slightly from the three months ended September 30, 2020 as a result of increased operating expenses, as discussed above. Net investment income for the nine months ended September 30, 2021 increased from the nine months ended September 30, 2021 as a result of portfolio growth.

#### Net Realized Gains and Losses

We measure realized gains or losses by the difference between the net proceeds from the repayment, sale or disposition and the amortized cost basis of the investment, using the specific identification method, without regard to unrealized appreciation or depreciation previously recognized.

Repayments and sales of investments and amortization of other certain investments for the three months ended September 30, 2021 totaled $67.6 ($123.6 Q3 YTD - $56.0 Q2 YTD from Q2 10-Q) million, and net realized gains totaled $7.9 million, primarily attributable to realizations of our equity investments in a few portfolio companies.

Repayments and sales of investments and amortization of other certain investments for the three months ended September 30, 2020 totaled $40.1 million, and net realized gains totaled $0.2 million.

Repayments and sales of investments and amortization of other certain investments for the nine months ended September 30, 2021 totaled $123.6 million, and net realized gains totaled $6.6 million, primarily attributable to realizations of our equity investments in a few portfolio companies.

Repayments and sales of investments and amortization of other certain investments for the nine months ended September 30, 2020 totaled $82.4 million, and net realized losses totaled ($2.4) million, primarily attributable to a loss on conversion of debt from a specific investment..

#### Net Change in Unrealized Appreciation (Depreciation) of Investments

Net change in unrealized appreciation (depreciation) primarily reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded appreciation or depreciation when gains or losses are realized.

Net change in unrealized appreciation on investments and cash equivalents for the three months ended September 30, 2021 and 2020 totaled $2.1 million and $2.1 million, respectively.

Net change in unrealized appreciation (depreciation) on investments and cash equivalents for the nine months ended September 30, 2021 and 2020 totaled $3.9 million and ($11.1) million, respectively.

The change in unrealized appreciation for the three and nine months ended September 30, 2021 was due primarily to the accounting reversal upon realization of one portfolio company.

#### Provision for Taxes on Unrealized Appreciation on Investments

We have direct wholly owned subsidiaries that have elected to be taxable entities (the “Taxable Subsidiaries”). The Taxable Subsidiaries permit us to hold equity investments in portfolio companies which are “pass through” entities for U.S. federal income tax purposes and continue to comply with the “source income” requirements contained in RIC tax provisions of the Code. The Taxable Subsidiaries are not consolidated with us for U.S. federal income tax purposes and may generate U.S. federal income tax expense, benefit, and the related tax assets and liabilities, as a result of their ownership of certain portfolio investments. The income tax expense, or benefit, if any, and related tax assets and liabilities are reflected in our consolidated financial statements. For the three months ended September 30, 2021 and 2020, we recognized a benefit (provision) for income tax on unrealized investments of ($606.4) thousand and ($92.7) thousand, respectively, for the Taxable Subsidiaries. For the nine months ended September 30, 2021 and 2020, we recognized a benefit (provision) for income tax on unrealized investments of ($586.5) thousand and ($122.7) thousand, respectively. As of September 30, 2021 and December 31, 2020, there was a deferred tax liability of $946.1 thousand and $359.6 thousand on the Consolidated Statement of Assets and Liabilities, respectively.

#### Net Increase in Net Assets Resulting from Operations

For the three months ended September 30, 2021, net increase in net assets resulting from operations totaled $12.8 million, or $0.66 per common share (based on 19,486,003 weighted-average common shares outstanding at September 30, 2021).

For the three months ended September 30, 2020, net increase in net assets resulting from operations totaled $7.5 million, or $0.39 per common share (based on 19,486,003 weighted-average common shares outstanding at September 30, 2020).

For the nine months ended September 30, 2021, net increase in net assets resulting from operations totaled $23.3 million, or $1.20 per common share (based on 19,486,003 weighted-average common shares outstanding at September 30, 2021).

For the nine months ended September 30, 2020, net decrease in net assets resulting from operations totaled $3.4 million, or $0.17 per common share (based on 19,466,647 weighted-average common shares outstanding at September 30, 2020).

The increase in net assets resulting from operations for the three months ended September 30, 2021 was higher than the increase in net assets resulting from operations for the three months ended September 30, 2020 primarily due to higher realized gains in the current period as compared to the prior period.

The increase in net assets resulting from operations for the nine months ended September 30, 2021 was higher than the increase in net assets resulting from operations for the nine months ended September 30, 2020 primarily due to higher realized gains and unrealized appreciation on investments, as compared to the prior period.

### Financial condition, liquidity and capital resources

### Cash Flows from Operating and Financing Activities

Our operating activities used net cash of ($102.1) million for the nine months ended September 30, 2021, primarily in connection with the purchase and origination of new portfolio investments, some of which was offset by repayment of portfolio investments. Our financing activities for the nine months ended September 30, 2021 provided cash of $121.4 million due to the issuance of our 2026 Notes offset by the repayment of our 2022 Notes, issuance of additional SBA-guaranteed debentures, and net repayments on our Credit Facility.

Our operating activities provided net cash of $12.4 million for the nine months ended September 30, 2020, primarily in connection with the unrealized appreciation of portfolio investments. Our financing activities for the nine months ended September 30, 2020 provided cash of $10.1 million due net borrowings under our Credit Facility.

### Liquidity and Capital Resources

Our liquidity and capital resources are derived from the Credit Facility, 2026 Notes, SBA-guaranteed debentures and cash flows from operations, including investment sales and repayments, and income earned. Our primary use of funds from operations includes investments in portfolio companies and other operating expenses we incur, as well as the payment of dividends to the holders of our common stock. We used, and expect to continue to use, these capital resources as well as proceeds from turnover within our portfolio and from public and private offerings of securities to finance our investment activities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from future public and private equity offerings and issuances of senior securities or future borrowings to the extent permitted by the 1940 Act, our plans to raise capital may not be successful. In this regard, if our common stock trades at a price below our then-current net asset value per share, we may be limited in our ability to raise equity capital given that we cannot sell our common stock at a price below net asset value per share unless our stockholders approve such a sale and our Board makes certain determinations in connection therewith. A proposal, approved by our stockholders at our 2021 annual stockholders meeting, authorizes us to sell up to 25% of our outstanding common shares at a price equal to or below the then current net asset value per share in one or more offerings. This authorization will expire on June 24, 2022, the one-year anniversary of our 2021 annual stockholders meeting. We would need similar future approval from our stockholders to issue shares below the then current net asset value per share any time after the expiration of the current approval. In addition, we intend to distribute between 90% and 100% of our taxable income to our stockholders in order to satisfy the requirements applicable to RICs under Subchapter M of the Code. Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. In addition, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, over the aggregate amount of the senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 150% effective June 29, 2018 (at least 200% prior to June 28, 2018). This requirement limits the amount that we may borrow. We have received exemptive relief from the SEC to permit us to exclude the debt of the SBIC subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. We were in compliance with the asset coverage ratios at all times. As of September 30, 2021 and December 31, 2020, our asset coverage ratio was 195% and 223%, respectively. The amount of leverage that we employ will depend on our assessment of market conditions and other factors at the time of any proposed borrowing, such as the maturity, covenant package and rate structure of the proposed borrowings, our ability to raise funds through the issuance of shares of our common stock and the risks of such borrowings within the context of our investment outlook. Ultimately, we only intend to use leverage if the expected returns from borrowing to make investments will exceed the cost of such borrowing. As of September 30, 2021 and December 31, 2020, we had cash and cash equivalents of $37.8 million and $18.5 million, respectively. Cash held within the SBIC subsidiaries is generally restricted to the origination of new SBIC-eligible loans and the payment of SBA debentures, related interest expense and fund-expenses. Distributions from positive retained earnings available for distribution are made to the BDC as provided in the SBICs’ limited partnership agreements.

### Credit Facility

On October 11, 2017, we entered a senior secured revolving credit agreement, dated as of October 10, 2017, as amended, that was amended and restated on September 18, 2020 with ZB, N.A., dba Amegy Bank and various other lenders (the “Credit Facility”).

The Credit Facility, as amended and restated, provides for borrowings up to a maximum of $230.0 million on a committed basis with an accordion feature that allows us to increase the aggregate commitments up to $280.0 million, subject to new or existing lenders agreeing to participate in the increase and other customary conditions.

Borrowings under the Credit Facility bear interest, subject to our election, on a per annum basis equal to (i) LIBOR plus 2.50% (or 2.75% during certain periods in which our asset coverage ratio is equal to or below 1.90 to 1.00) with a 0.25% LIBOR floor, or (ii) 1.50% (or 1.75% during certain periods in which our asset coverage ratio is equal to or below 1.90 to 1.00) plus an alternate base rate based on the highest of the Prime Rate (subject to a 3% floor), Federal Funds Rate plus 0.5% or one month LIBOR plus 1.0%. We pay unused commitment fees of 0.50% per annum on the unused lender commitments under the Credit Facility. Interest is payable monthly or quarterly in arrears. The commitment to fund the revolver expires on September 18, 2024, after which we may no longer borrow under the Credit Facility and must begin repaying principal equal to 1/12 of the aggregate amount outstanding under the Credit Facility each month. Any amounts borrowed under the Credit Facility will mature, and all accrued and unpaid interest thereunder will be due and payable, on September 18, 2025.

Our obligations to the lenders are secured by a first priority security interest in our portfolio of securities and cash not held at the SBIC subsidiaries, but excluding short term investments. The Credit Facility contains certain covenants, including but not limited to: (i) maintaining a minimum liquidity test of at least $10,000,000, including cash, liquid investments and undrawn availability, (ii) maintaining an asset coverage ratio of at least 1.67 to 1.0, (iii) maintaining a minimum shareholder’s equity, and (iv) maintaining a minimum interest coverage ratio of at least 2.00 to 1.00. As of September 30, 2021, we were in compliance with these covenants.

As of September 30, 2021 and December 31, 2020, the outstanding balance under the Credit Facility was $189.8 million and $174.0 million, respectively. The carrying amount of the amount outstanding under the Credit Facility approximates its fair value. The fair values of the Credit Facility is determined in accordance with ASC Topic 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of the Credit Facility is estimated based upon market interest rates for our own borrowings or entities with similar credit risk, adjusted for nonperformance risk, if any. We incurred costs of $3.7 million in connection with the Credit Facility, which are being amortized over the life of the facility. Additionally, $0.3 million of costs from a prior credit facility will continue to be amortized over the remaining life of the Credit Facility. As of September 30, 2021 and December 31, 2020, $1.9 million and $2.3 million of such prepaid loan structure fees and administration fees had yet to be amortized, respectively. These prepaid loan fees are presented on our consolidated statement of assets and liabilities as a deduction from the debt liability.

Interest is payable monthly or quarterly in arrears. The following table summarizes the interest expense and amortized loan fees on the Credit Facility for the three and nine months ended September 30, 2021 and 2020 (in millions):

|  | For the three months ended September 30, 2021 | September 30, 2020 | For the nine months ended September 30, 2021 | September 30, 2020 |
| --- | ---: | ---: | ---: | ---: |
| Interest expense | $1.4 | $1.3 | $3.7 | $4.7 |
| Loan fee amortization | 0.1 | 0.2 | 0.4 | 0.5 |
| Commitment fees on unused portion | 0.1 | - | 0.2 | 0.1 |
| Total interest and financing expenses | $1.6 | $1.5 | $4.3 | $5.3 |
| Weighted average interest rate | 2.8% | 2.8% | 2.8% | 3.3% |
| Effective interest rate (including fee amortization) | 3.2% | 3.4% | 3.3% | 3.8% |
| Average debt outstanding | $191.9 | $181.1 | $174.1 | $187.2 |
| Cash paid for interest and unused fees | $1.4 | $1.3 | $3.9 | $5.0 |

70

### SBA-Guaranteed Debentures

Due to the SBIC subsidiaries’ status as licensed SBICs, we have the ability to issue debentures guaranteed by the SBA at favorable interest rates. Under the regulations applicable to SBIC funds, a single licensee can have outstanding debentures guaranteed by the SBA subject to a regulatory leverage limit, up to two times the amount of regulatory capital. As of both September 30, 2021 and December 31, 2020, the SBIC subsidiary had $75.0 million in regulatory capital, as such term is defined by the SBA, and $150.0 million of SBA-guaranteed debentures outstanding.

As of September 30, 2021 and December 31, 2020, the SBIC II subsidiary had $87.5 million and $40.0 million in regulatory capital and $100.0 million and $26.5 million of SBA-guaranteed debentures outstanding, respectively. See Note 10 to the Consolidated Financial Statements for further detail on the SBA-guaranteed debentures outstanding.

On August 12, 2014, we obtained exemptive relief from the SEC to permit us to exclude the debt of the SBIC subsidiaries guaranteed by the SBA from our 200% asset coverage test under the 1940 Act. The exemptive relief provides us with increased flexibility under the 200% asset coverage test by permitting us to borrow up to $325.0 million more than we would otherwise be able to absent the receipt of this exemptive relief.

On a stand-alone basis, the SBIC subsidiaries held $403.2 million and $277.4 million in assets at September 30, 2021 and December 31, 2020, respectively, which accounted for approximately 48.8% and 41.1% of our total consolidated assets at September 30, 2021 and December 31, 2020, respectively.

SBA-guaranteed debentures have fixed interest rates that equal prevailing 10-year U.S. Treasury Note rates plus a market spread and have a maturity of ten years with interest payable semi-annually. The principal amount of the debentures is not required to be paid before maturity but may be pre-paid at any time with no prepayment penalty. SBA-guaranteed debentures drawn before October 1, 2019 incurred upfront fees of 3.425%, which consisted of a 1.00% commitment fee and a 2.425% issuance discount, which are being amortized over the life of the SBA-guaranteed debentures. SBA-guaranteed debentures drawn after October 1, 2019 incur upfront fees of 3.435%, which consists of a 1.00% commitment fee and a 2.435% issuance discount, which are amortized over the life of the SBA-guaranteed debentures. Once pooled, which occurs in March and September of each applicable year, the SBA-guaranteed debentures bear interest at a fixed rate that is set to the current 10-year treasury rate plus a spread at each pooling date.

As of September 30, 2021 and December 31, 2020, the carrying amount of the SBA-guaranteed debentures approximated their fair value. The fair values of the SBA-guaranteed debentures are determined in accordance with ASC Topic 820, which defines fair value in terms of the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The fair value of the SBA-guaranteed debentures are estimated based upon market interest rates for our own borrowings or entities with similar credit risk, adjusted for nonperformance risk, if any. At September 30, 2021 and December 31, 2020 the SBA-guaranteed debentures would be deemed to be Level 3 as defined in Note 6 to the Consolidated Financial Statements).

As of September 30, 2021, we have incurred $9.3 million in financing costs related to the SBA-guaranteed debentures since the SBIC subsidiaries received their licenses, which were recorded as prepaid loan fees. As of September 30, 2021 and December 31, 2020, $5.7 million and $3.3 million of prepaid financing costs had yet to be amortized, respectively. These prepaid financing costs are presented on the consolidated statement of assets and liabilities as a deduction from the debt liability.

The following table summarizes the interest expense and amortized fees on the SBA-guaranteed debentures for the three and nine months ended September 30, 2021 and 2020 (in millions):

|  | For the three months ended September 30, 2021 | September 30, 2020 | For the nine months ended September 30, 2021 | September 30, 2020 |
| --- | ---: | ---: | ---: | ---: |
| Interest expense | $1.7 | $1.3 | $4.6 | $4.0 |
| Debenture fee amortization | 0.3 | 0.2 | 0.8 | 0.5 |
| Total interest and financing expenses | $2.0 | $1.5 | $5.4 | $4.5 |
| Weighted average interest rate | 2.7% | 3.3% | 2.8% | 3.3% |
| Effective interest rate (including fee amortization) | 3.2% | 3.8% | 3.3% | 3.8% |
| Average debt outstanding | $246.2 | $161.0 | $220.4 | $161.0 |
| Cash paid for interest | $3.2 | $2.7 | $5.9 | $5.3 |

### Notes Offering

On August 21, 2017, we issued $42.5 million in aggregate principal amount of 5.75% fixed-rate notes due September 15, 2022 (the “2022 Notes”). On September 8, 2017, we issued an additional $6.38 million in aggregate principal amount of the 2022 Notes pursuant to a full exercise of the underwriters’ overallotment option. On January 13, 2021, we caused notices to be issued to the holders of its 2022 Notes regarding the Company’s exercise of its option to redeem all of the issued and outstanding 2022 Notes, pursuant to the Second Supplemental Indenture dated as of August 21, 2017, between the Company and U.S. Bank National Association, as trustee. We redeemed all $48.875 million in aggregate principal amount of the 2022 Notes on February 12, 2021. The 2022 Notes were redeemed at 100% of their principal amount, plus the accrued and unpaid interest thereon through the redemption date. As a result of the redemption, we recognized a loss on debt extinguishment of $0.5 million due to the write off of the remaining deferred financing costs on the 2022 Notes. This loss is included in the Consolidated Statement of Operations for the nine months ended September 30, 2021.

The following table summarizes the interest expense and deferred financing costs on the 2022 Notes for the three and nine months ended September 30, 2021 and 2020 (dollars in millions):

|  | For the three months ended September 30, 2021 | September 30, 2020 | For the nine months ended September 30, 2021 | September 30, 2020 |
| --- | ---: | ---: | ---: | ---: |
| Interest expense | $- | $0.7 | $0.3 | $2.1 |
| Deferred financing costs | - | 0.1 | 0.1 | 0.3 |
| Total interest and financing expenses | $- | $0.8 | $0.4 | $2.4 |
| Loss on extinguishment of debt (1) | - | - | 0.5 | - |
| Weighted average interest rate (2) | 0.0% | 5.7% | 5.7% | 5.7% |
| Effective interest rate (including fee amortization) (2) | 0.0% | 6.4% | 6.4% | 6.4% |
| Average debt outstanding (3) | $- | $48.9 | $48.9 | $48.9 |
| Cash paid for interest | $- | $0.7 | $0.5 | $2.1 |

(1) The loss on debt extinguishment is not included in interest expense or net investment income

(2) Excludes the loss on debt extinguishment

(3) For the nine months ended September 30, 2021, the average is calculated for the period January 1, 2021 through February 12, 2021; the repayment date of the 2022 Notes

On January 14, 2021, we issued $100.0 million in aggregate principal amount of 4.875% fixed-rate notes due 2026 (the “2026 Notes”). The 2026 Notes will mature on March 30, 2026, and may be redeemed in whole or in part at any time or from time to time at our option on or after December 31, 2025 at a redemption price equal to 100% of the outstanding principal, plus accrued and unpaid interest. Interest is payable semi-annually beginning September 30, 2021

We used the net proceeds from this offering to fully redeem the 2022 Notes and repay a portion of the amount outstanding under the Credit Facility. As of September 30, 2021, the aggregate carrying amount of the 2026 Notes were approximately $100.0 million.

Prior to their redemption on February 12, 2021, the 2022 Notes were listed on New York Stock Exchange under the trading symbol “SCA”. As of December 31, 2020, the fair value of the 2022 Notes was $49.2 million. The 2026 Notes are institutional, non-traded notes. The carrying value of the 2026 Notes approximates fair value.

In connection with the issuance of the 2026 Notes, we have incurred $2.3 million of fees which are being amortized over the term of the 2026 Notes, of which $2.0 million remains to be amortized as of September 30, 2021. These financing costs are presented on the consolidated statement of assets and liabilities as a deduction from the debt liability.

The following table summarizes the interest expense and deferred financing costs on the 2026 Notes for the three and nine months ended September 30, 2021 and 2020 (dollars in millions):

|  | For the three months ended September 30, 2021 | September 30, 2020 | For the nine months ended September 30, 2021 | September 30, 2020 |
| --- | ---: | ---: | ---: | ---: |
| Interest expense | $1.2 | $- | $3.5 | $- |
| Deferred financing costs | 0.1 | - | 0.3 | - |
| Total interest and financing expenses | $1.3 | $- | $3.8 | $- |
| Weighted average interest rate | 4.8% | 0.0% | 4.9% | 0.0% |
| Effective interest rate (including fee amortization) | 5.3% | 0.0% | 5.3% | 0.0% |
| Average debt outstanding (1) | $100.0 | $- | $100.0 | $- |
| Cash paid for interest | $3.5 | $- | $3.5 | $- |

(1) Calculated for the period from January 14, 2021, the date of the 2026 Notes offering, through September 30, 2021.

### Off-Balance Sheet Arrangements

We may be a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financial needs of our portfolio companies. As of September 30, 2021 and December 31, 2020, our off-balance sheet arrangements consisted of $27.3 million and $28.9 million, respectively, of unfunded commitments to provide debt financing to 25 and 19 of our portfolio companies, respectively. As of September 30, 2021, we had sufficient liquidity to fund such unfunded commitments (through cash on hand and available borrowings under the Credit Facility) should the need arise.

### Regulated Investment Company Status and Dividends

We have elected to be treated as a RIC under Subchapter M of the Code and intend to operate in a manner to qualify annually for the tax treatment applicable to RICs. So long as we maintain our qualification as a RIC, we will not be taxed on our investment company taxable income or realized net capital gains, to the extent that such taxable income or gains are distributed, or deemed to be distributed, to stockholders as dividends on a timely basis.

Taxable income generally differs from net income for financial reporting purposes due to temporary and permanent differences in the recognition of income and expenses, and generally excludes net unrealized appreciation or depreciation until realized. Distributions declared and paid by us in a year may differ from taxable income for that year as such dividends may include the distribution of current year taxable income or the distribution of prior year taxable income carried forward into and distributed in the current year. Distributions also may include returns of capital.

To qualify for RIC tax treatment, we must, among other things, distribute, with respect to each taxable year, at least 90% of our investment company net taxable income (i.e., our net ordinary income and our realized net short-term capital gains in excess of realized net long-term capital losses, if any). If we maintain our qualification as a RIC, we must also satisfy certain distribution requirements each calendar year in order to avoid a U.S. federal excise tax on our undistributed earnings of a RIC. As of December 31, 2020, the Company had $21,051,549 of undistributed taxable income that was carried forward toward distributions paid during the year ending December 31, 2021.

We intend to distribute to our stockholders between 90% and 100% of our annual taxable income (which includes our taxable interest and fee income). However, the covenants contained in the Credit Facility may prohibit us from making distributions to our stockholders, and, as a result, could hinder our ability to satisfy the distribution requirement. In addition, we may retain for investment some or all of our net taxable capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) and treat such amounts as deemed distributions to our stockholders. If we do this, our stockholders will be treated as if they received actual distributions of the capital gains we retained and then reinvested the net after-tax proceeds in our common stock. Our stockholders also may be eligible to claim tax credits (or, in certain circumstances, tax refunds) equal to their allocable share of the tax we paid on the capital gains deemed distributed to them. To the extent our taxable earnings for a fiscal taxable year fall below the total amount of our dividends for that fiscal year, a portion of those dividend distributions may be deemed a return of capital to our stockholders.

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, we may be limited in our ability to make distributions due to the asset coverage test for borrowings applicable to us as a business development company under the 1940 Act and due to provisions in the Credit Facility. We cannot assure stockholders that they will receive any distributions or distributions at a particular level.

In accordance with certain applicable U.S. Treasury regulations and private letter rulings issued by the Internal Revenue Service (the “IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC, subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash must receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20% of his or her entire distribution in cash, except as described below.

If these and certain other requirements are met, for U.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock. We have no current intention of paying dividends in shares of our stock in accordance with these U.S. Treasury regulations or private letter rulings. However, we continue to monitor the Company’s liquidity position and the overall economy and will continue to assess whether it would be in the best interests of the Company and its shareholders’ to take advantage of the IRS rulings.

### Recent Accounting Pronouncements

See Note 1 to the Consolidated Financial Statements contained herein for a description of recent accounting pronouncements, if any, including the expected dates of adoption and the anticipated impact on the financial statements.

### Critical Accounting Policies

See Note 1 to the Consolidated Financial Statements contained herein for a description of critical accounting policies.

### Subsequent Events

### Credit Facility

The outstanding balance under the Credit Facility as of October 27, 2021 was $185.9 million.

### SBA-guaranteed Debentures

The total consolidated balance of SBA-guaranteed debentures outstanding as of October 27, 2021 was $250.0 million.

## Market risk

As filed, 2,501 characters.

We are subject to financial market risks, including changes in interest rates. As of September 30, 2021 and December 31, 2020, 95% and 93% of the loans in our portfolio bore interest at floating rates, respectively. These floating rate loans typically bear interest in reference to LIBOR, and are indexed to 30-day, 90-day or 120-day LIBOR rates, subject to an interest rate floor. As of September 30, 2021 and December 31, 2020, the weighted average interest rate floor on our floating rate loans was 1.18% and 1.21%, respectively.

Assuming that the Statement of Assets and Liabilities as of September 30, 2021 were to remain constant and no actions were taken to alter the existing interest rate sensitivity, the following table shows the annual impact on net income of changes in interest rates:

*(dollars in millions)*

| Change in Basis Points(2) | Interest Income | Interest Expense (3) | Net Interest Income (1) |
| --- | ---: | ---: | ---: |
| Up 200 basis points | $7.4 | (3.8) | $3.6 |
| Up 150 basis points | 4.1 | (2.8) | 1.3 |
| Up 100 basis points | 1.5 | (1.9) | (0.4) |
| Up 50 basis points | 0.5 | (0.9) | (0.4) |

(1) Excludes the impact of incentive fees based on pre-incentive fee net investment income. See Note 2 to the Consolidated Financial Statements for more information on the incentive fee.

(2) The three month LIBOR rate at September 30, 2021 was 13 basis points. This table assumes LIBOR would not fall below zero.

(3) Includes the impact of the 25 basis points LIBOR floor in place on the Credit Facility.

Although we believe that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the balance sheet and other business developments that could affect net increase in net assets resulting from operations. Accordingly, no assurances can be given that actual results would not differ materially from the potential outcome simulated by this estimate. We may hedge against interest rate fluctuations by using standard hedging instruments such as futures, options and forward contacts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in the benefits of lower interest rates with respect to our portfolio of investments. For the three and nine months ended September 30, 2021 and 2020, we did not engage in hedging activities.

## Controls and procedures

As filed, 1,058 characters.

### (a) Evaluation of Disclosure Controls and Procedures

The Company’s management, under the supervision and with the participation of various members of management, including its Chief Executive Officer and its Chief Financial Officer, has evaluated the effectiveness of its disclosure controls and procedures (as defined in Rule 13a-15(e) or Rule 15d-15(e) of the Securities and Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

### (b) Changes in Internal Control Over Financial Reporting

The Company’s management did not identify any change in the Company’s internal control over financial reporting that occurred during the quarter ended September 30, 2021 that has materially affected, or is reasonable likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 6,075 characters.

Other than as set forth below, there have been no material changes in the information provided under the heading “Risk Factors” in our Annual Report on Form 10-K as of December 31, 2020. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may materially affect our business, financial condition and/or operating results.

***The COVID-19 pandemic has caused severe disruptions in the global economy, which has had, and may continue to have, a negative impact on our portfolio companies and our business and operations.***

As of the filing date of this Quarterly Report, there is a continued outbreak of the COVID-19 pandemic, for which the World Health Organization has declared a global pandemic and the United States has declared a national emergency. Many states, including those in which we and our portfolio companies operate, have issued orders requiring the closure of, or certain restrictions on the operation of, non-essential businesses and/or requiring residents to stay at home. The COVID-19 pandemic and restrictive measures taken to contain or mitigate its spread have caused, and are continuing to cause, business shutdowns, or the re-introduction of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. Such effects will likely continue for the duration of the pandemic, which is uncertain, and for some period thereafter. While several countries, as well as certain states, counties and cities in the United States, began to relax the early public health restrictions with a view to partially or fully reopening their economies, many cities, both globally and in the United States, have since experienced a surge in the reported number of cases, hospitalizations and deaths related to the COVID-19 pandemic. This recent increase in cases led to the re-introduction of restrictions and business shutdowns in certain states, counties and cities in the United States and globally and could continue to lead to such restrictions elsewhere. Beginning in December 2020, the U.S. Food and Drug Administration authorized certain vaccines for emergency use. However, it remains unclear how quickly the vaccines will be distributed or when “herd immunity” will be achieved and the restrictions that were imposed to slow the spread of the virus will be lifted entirely. Delays in distributing the vaccines or an actual or perceived failure to achieve “herd immunity” could lead people to continue to refrain from participating in the economy at pre-pandemic levels for a prolonged period of time. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and our business and operations, as well as the business and operations of our portfolio companies, could be materially adversely affected by a prolonged recession in the U.S. and other major markets.

The COVID-19 pandemic (including the restrictive measures taken in response thereto) has to date (i) created significant business disruption issues for certain of our portfolio companies, and (ii) materially and adversely impacted the value and performance of certain of our portfolio companies. The COVID-19 pandemic is having a particularly adverse impact on industries in which certain of our portfolio companies operate, including energy, hospitality, travel, retail and restaurants. Certain of our portfolio companies in other industries have also been significantly impacted. The COVID-19 pandemic is continuing as of the filing date of this Quarterly Report, and its extended duration may have further adverse impacts on our portfolio companies after September 30, 2021, including for the reasons described below. Although the U.S. government enacted the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) on March 27, 2020, which contains provisions intended to mitigate the adverse economic effects of the COVID-19 pandemic, and a second and third stimulus package on December 27, 2020 and March 11, 2021, respectively, which provided $900 billion and $1.9 trillion, respectively, in resources to small businesses and individuals as well as certain industries and state and local governments that have been adversely affected by the COVID-19 pandemic, it is uncertain whether, or how much, our portfolio companies have benefited or may benefit from such legislation or any other subsequent legislation intended to provide financial relief or assistance. As a result of this disruption and the pressures on their liquidity, certain of our portfolio companies have drawn, particularly in the beginning of the COVID-19 pandemic, on a higher percentage of the available revolving loans made available by us. While the levels of draw on available revolving loans have generally returned to pre-COVID-19 pandemic levels, some of our portfolio companies with such available revolving loans may draw or continue to draw on such loans at a higher level than before the COVID-19 pandemic, subject to availability under the terms of such loans.

***Our investments in the aerospace & defense industry are subject to unique risks relating to technological developments, regulatory changes and global economic conditions.***

Our investments in portfolio companies that operate in the aerospace & defense industry represent 10.16% of our total portfolio as of September 30, 2021. Portfolio companies in the aerospace & defense sector are subject to many risks, including the negative impact of regulation, changing technology, a competitive marketplace and difficulty in obtaining financing. Any of these factors could materially and adversely affect the operations of a portfolio company in this industry and, in turn, impair our ability to timely collect principal and interest payments owed to us.

Filed Oct 28, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-131054. Last ingested by Listed: Nov 10, 2026, 21:35 ET. No prices; not investment advice.
